| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.028 | 0.6 |